CARDIOVASCULAR JOURNAL OF AFRICA • Vol 24, No 6, July 2013
236
AFRICA
MC. Functional effects of mutations in KvLQT1 that cause long QT
syndrome.
J Cardiovasc Electrophysiol
1999;
10
(6): 817–826.
28. Wedekind H, Schwarz M, Hauenschild S, Djonlagic H, Haverkamp W,
Breithardt G,
et al
. Effective long-term control of cardiac events with
beta-blockers in a family with a common LQT1 mutation.
Clin Genet
2004;
65
(3): 233–241.
29. Bianchi L, Priori SG, Napolitano C, Surewicz KA, Dennis AT, Memmi
M,
et al
. Mechanisms of I(Ks) suppression in LQT1 mutants.
Am J
Physiol Heart Circ Physiol
2000;
279
(6): H3003–11.
30. Paulussen AD, Gilissen RA, Armstrong M, Doevendans PA, Verhasselt
P, Smeets HJ,
et al
. Genetic variations of KCNQ1, KCNH2, SCN5A,
KCNE1, and KCNE2 in drug-induced long QT syndrome patients.
J
Molec Med
2004;
82
(3): 182–188.
31. Jongbloed RJ, Wilde AA, Geelen JL, Doevendans P, Schaap C, Van
Langen I,
et al
. Novel KCNQ1 and HERG missense mutations in Dutch
long-QT families.
Hum Mutation
1999;
13
(4): 301–310.
32. Berthet M, Denjoy I, Donger C, Demay L, Hammoude H, Klug D,
et al
.
C-terminal HERG mutations: the role of hypokalemia and a KCNQ1-
associated mutation in cardiac event occurrence.
Circulation
1999;
99
(11): 1464–1470.
33. Choi G, Kopplin LJ, Tester DJ, Will ML, Haglund CM, Ackerman MJ.
Spectrum and frequency of cardiac channel defects in swimming-trig-
gered arrhythmia syndromes.
Circulation
2004;
110
(15): 2119–2124.
34. Siebrands CC, Binder S, Eckhoff U, Schmitt N, Friederich P. Long QT
1 mutation KCNQ1A344V increases local anesthetic sensitivity of the
slowly activating delayed rectifier potassium current.
Anesthesiology
2006;
105
(3): 511–520.
35. Biliczki P, Girmatsion Z, Brandes RP, Harenkamp S, Pitard B,
Charpentier F,
et al
. Trafficking-deficient long QT syndrome muta-
tion KCNQ1-T587M confers severe clinical phenotype by impairment
of KCNH2 membrane localization: evidence for clinically signifi-
cant IKr-IKs alpha-subunit interaction.
Heart Rhythm
2009;
6
(12):
1792–1801.
36. Yamashita F, Horie M, Kubota T, Yoshida H, Yumoto Y, Kobori A,
et
al
. Characterization and subcellular localization of KCNQ1 with a
heterozygous mutation in the C terminus.
J Molec Cell Cardiol
2001;
33
(2):197–207.
37. Furushima H, Chinushi M, Sato A, Aizawa Y, Kikuchi A, Takakuwa
K,
et al
. Fetal atrioventricular block and postpartum augmentative QT
prolongation in a patient with long-QT syndrome with KCNQ1 muta-
tion.
J Cardiovasc Electrophysiol
2010;
21
(10): 1170–1173.
38. Millat G, Chevalier P, Restier-Miron L, Da Costa A, Bouvagnet P,
Kugener B,
et al
. Spectrum of pathogenic mutations and associ-
ated polymorphisms in a cohort of 44 unrelated patients with long QT
syndrome.
Clin Genet
2006;
70
(3): 214–227.
39. Anderson CL, Delisle BP, Anson BD, Kilby JA, Will ML, Tester DJ,
et
al
. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2
(trafficking-deficient) mechanism.
Circulation
2006;
113
(3): 365–373.
40. Kapa S, Tester DJ, Salisbury BA, Harris-Kerr C, Pungliya MS, Alders
M,
et al
. Genetic testing for long-QT syndrome: distinguishing
pathogenic mutations from benign variants.
Circulation
2009;
120
(18):
1752–1760.
41. Fodstad H, Swan H, Laitinen P, Piippo K, Paavonen K, Viitasalo M,
et
al
. Four potassium channel mutations account for 73% of the genetic
spectrum underlying long-QT syndrome (LQTS) and provide evidence
for a strong founder effect in Finland.
Ann Med
2004;
36
(Suppl 1):
53–63.
42. Liu WL, Hu DY, Li P, Li CL, Qin XG, Li YT,
et al
. [Novel mutations
of potassium channel KCNQ1 S145L and KCNH2 Y475C genes in
Chinese pedigrees of long QT syndrome].
Zhonghua nei ke za zhi
[
Chinese J Int Med
] 2006;
45
(6): 463–466.
43. Chung SK, MacCormick JM, McCulley CH, Crawford J, Eddy CA,
Mitchell EA,
et al
. Long QT and Brugada syndrome gene mutations in
New Zealand.
Heart Rhythm
2007;
4
(10): 1306–1314.
44. Zhao JT, Hill AP, Varghese A, Cooper AA, Swan H, Laitinen-Forsblom
PJ, et
al
. Not all hERG pore domain mutations have a severe phenotype:
G584S has an inactivation gating defect with mild phenotype compared
to G572S, which has a dominant negative trafficking defect and a
severe phenotype.
J Cardiovasc Electrophysiol
2009;
20
(8): 923–930.
45. Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, Robinson JL,
et al
. Spectrum of mutations in long-QT syndrome genes. KVLQT1,
HERG, SCN5A, KCNE1, and KCNE2.
Circulation
2000;
102
(10):
1178–1185.
46. Lin MT, Wu MH, Chang CC, Chiu SN, Theriault O, Huang H,
et al
.
In utero
onset of long QT syndrome with atrioventricular block and
spontaneous or lidocaine-induced ventricular tachycardia: compound
effects of hERG pore region mutation and SCN5A N-terminus variant.
Heart Rhythm
2008;
5
(11): 1567–1574.
47. Chevalier P, Rodriguez C, Bontemps L, Miquel M, Kirkorian G,
Rousson R,
et al
. Non-invasive testing of acquired long QT syndrome:
evidence for multiple arrhythmogenic substrates.
Cardiovasc Res
2001;
50
(2): 386–398.
48. Grunnet M, Behr ER, Calloe K, Hofman-Bang J, Till J, Christiansen
M,
et al.
Functional assessment of compound mutations in the KCNQ1
and KCNH2 genes associated with long QT syndrome.
Heart Rhythm
2005;
2
(11): 1238–1249.
49. Christiansen M, Wettrell G, Larsen LA, Lundqvist L, Andersen PS,
Kanters JK, Vuust J. Potassium must be considered in congenital long
QT syndrome.
Heart Drug
2005;
5
(1): 54–58.
50. Kaab S, Schulze-Bahr E. Susceptibility genes and modifiers for cardiac
arrhythmias.
Cardiovasc Res
2005;
67
(3): 397–413.
51. Laohakunakorn P, Benson DW, Yang P, Yang T, Roden DM, Kugler JD.
Bidirectional ventricular tachycardia and channelopathy.
Am J Cardiol
2003;
92
(8): 991–995.
52. Heradien MGA, Moolman-Smook JC, Brink PA. Race and gender
representation of hypertrophic cardiomyopathy or long QT syndrome
cases in a South African research setting : review article.
Cardiovasc J
Afr
2007;
18
(5): 308–311.
53. Koopmann TT, Alders M, Jongbloed RJ, Guerrero S, Mannens MM,
Wilde AA,
et al
. Long QT syndrome caused by a large duplication in
the KCNH2 (HERG) gene undetectable by current polymerase chain
reaction-based exon-scanning methodologies.
Heart Rhythm
2006;
3
(1): 52–55.
54. Zaklyazminskaya EV, Abriel H. Prevalence of significant genetic
variants in congenital long QT syndrome is largely underestimated.
Frontiers Pharmacol
2012;
3
: 72.
55. Paulussen A, Matthijs G, Gewillig M, Verhasselt P, Cohen N, Aerssens
J. Mutation analysis in congenital long QT syndrome – a case with
missense mutations in KCNQ1 and SCN5A.
Genet Test
2003;
7
(1):
57–61.
56. Struijk JJ, Kanters JK, Andersen MP, Hardahl T, Graff C, Christiansen
M,
et al
. Classification of the long-QT syndrome based on discriminant
analysis of T-wave morphology.
Med Biol Engineer Comput
2006;
44
(7): 543–549.
57. Moss AJ, Shimizu W, Wilde AA, Towbin JA, Zareba W, Robinson JL,
et al
. Clinical aspects of type-1 long-QT syndrome by location, coding
type, and biophysical function of mutations involving the KCNQ1 gene.
Circulation
2007;
115
(19): 2481–2489.
58. Barsheshet A, Goldenberg I, Ou J, Moss AJ, Jons C, Shimizu W,
et al
.
Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of
life-threatening events: implications for mutation-specific response to
beta-blocker therapy in type 1 long-QT syndrome.
Circulation
2012;
125
(16): 1988–1996.
59. Chen S, Zhang L, Bryant RM, Vincent GM, Flippin M, Lee JC,
et al
.
KCNQ1 mutations in patients with a family history of lethal cardiac
arrhythmias and sudden death.
Clin Genet
2003;
63
(4): 273–282.
60. Splawski I, Shen J, Timothy KW, Vincent GM, Lehmann MH, Keating
MT. Genomic structure of three long QT syndrome genes: KVLQT1,
HERG, and KCNE1.
Genomics
1998;
51
(1): 86–97.
61. Napolitano C, Schwartz PJ, Brown AM, Ronchetti E, Bianchi L,
Pinnavaia A,
et al
. Evidence for a cardiac ion channel mutation underly-
ing drug-induced QT prolongation and life-threatening arrhythmias.
J
Cardiovasc Electrophysiol
2000;
11
(6): 691–696.
62. Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long-QT
syndrome: clinical impact.
Circulation
1999;
99
(4): 529–533.
63. Goldman AM, Glasscock E, Yoo J, Chen TT, Klassen TL, Noebels JL.
Arrhythmia in heart and brain: KCNQ1 mutations link epilepsy and
sudden unexplained death.
Sci Translat Med
2009;
1
(2): 2ra6.
